TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04708041

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection
Study: NCT05141435

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: infants receive primary non-invasive respiratory support by mean of NHFOV
Description: neonates assigned to NHFOV will be started with the following boundaries: a) Paw of 6 cmH2O (the range 6-10 cmH2O); b) frequency of 10 Hz (the range 8-12 Hz). c) Inspiratory time 50% (1:1). d) amplitude 15 cmH2O(the range 15-25 cmH2O) NHFOV will only be provided with piston/ membrane oscillators able to provide an active expiratory phase (that is, Acutronic FABIAN-III, SLE 5000, Loweinstein Med LEONI+, Sensormedics 3100A).

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: infants receive primary non-invasive respiratory support by mean of NHFOV
Description: neonates assigned to NHFOV will be started with the following boundaries: a) Paw of 6 cmH2O (the range 6-10 cmH2O); b) frequency of 10 Hz (the range 8-12 Hz). c) Inspiratory time 50% (1:1). d) amplitude 15 cmH2O(the range 15-25 cmH2O) NHFOV will only be provided with piston/ membrane oscillators able to provide an active expiratory phase (that is, Acutronic FABIAN-III, SLE 5000, Loweinstein Med LEONI+, Sensormedics 3100A).
Study: NCT04708041

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: 9vHPV vaccine
Description: 9-valent human papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) administered as a 0.5-mL intramuscular injection
Study: NCT05875025

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo formulated with HFA-152a propellant via pMDI
Description: 5 inhalations BID (morning and evening) for 8 consecutive days, starting from the morning of Day 1 until the morning of Day 8

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo formulated with HFA-134a propellant via pMDI
Description: 5 inhalations BID (morning and evening) for 8 consecutive days, starting from the morning of Day 1 until the morning of Day 8
Study: NCT05706220

Intervention type: DIAGNOSTIC_TEST
Intervention: Eye tracking
Description: Eye tracker will be used to evaluate eye movements

Intervention type: DIAGNOSTIC_TEST
Intervention: Eye tracking
Description: Eye tracker will be used to evaluate eye movements
Study: NCT05693610

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable OSP
Description: The portable open-source speech processing platform (OSP) is accessed on a browser via a wireless fidelity (WiFi)-enabled portable communication device that carries out all the signal processing. The processed sounds are transmitted to the ears via earpieces known as behind-the-ear receivers in the canal (same as those available with commercial hearing aids). The amount of amplification with the portable OSP will be customized for each listener based on a validated prescription.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cloud-based OSP
Description: The cloud-based open-source speech processing platform (OSP) is hosted on a web-server which includes the software for all the signal processing. The processed sounds are transmitted to the ears via calibrated headphones. The amount of amplification with the cloud-based OSP will be customized for each listener based on a validated prescription.
Study: NCT04793958

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MRTX849
Description: 28 Day Cycle

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: 28 Day Cycle

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mFOLFOX6 Regimen
Description: * Fluorouracil~* Oxaliplatin~* Folinic acid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI Regimen
Description: * Fluorouracil~* Irinotecan~* Folinic acid
Study: NCT05175599

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Water Birth
Description: The water birth group will use a tub of a water to labor and give birth.
Study: NCT05426564

Intervention type: DIAGNOSTIC_TEST
Intervention: Quantra System
Description: Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Study: NCT06262061

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propranolol
Description: 20mg oral propranolol BID x 14 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill orally BID x 14 days
Study: NCT05416255

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Measuring synovial fluid components
Description: Using speialized techniques to measure S.F. components

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Measuring synovial fluid components
Description: Using speialized techniques to measure S.F. components

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Measuring synovial fluid components
Description: Using speialized techniques to measure S.F. components

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Measuring synovial fluid components
Description: Using speialized techniques to measure S.F. components
Study: NCT06478056

Intervention type: PROCEDURE
Group type: OTHER
Intervention: pancreatectomy
Description: patients operated on for pancreatic adenocarcinoma in the digestive surgery department of Rouen University Hospital
Study: NCT05880459

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol and magnesium sulphate ,propofol and nalbuphine
Description: The patients will be randomly divided into 2 groups by using a computer-generated randomization tableAll patients will fast from solids for 8 h and from liquids for 2 h. After arrival at preoperative area an intravenous cannula will be placed in the peripheral vein of right hand for fluid infusion and medicine administration.~All of the patients will be interviewed by the patient sedation satisfaction assessment tool (PSSI) regarding their experience 1 hour after the operation.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol and magnesium sulphate ,propofol and nalbuphine
Description: The patients will be randomly divided into 2 groups by using a computer-generated randomization tableAll patients will fast from solids for 8 h and from liquids for 2 h. After arrival at preoperative area an intravenous cannula will be placed in the peripheral vein of right hand for fluid infusion and medicine administration.~All of the patients will be interviewed by the patient sedation satisfaction assessment tool (PSSI) regarding their experience 1 hour after the operation.
Study: NCT05021757

Intervention type: DEVICE
Intervention: Shockwave C2 Coronary IVL
Description: PCI procedure using a Shockwave C2 coronary IVL catheter
Study: NCT05930002

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Tablets
Description: oral tablets (0.2 mg/kg/day) single dose on an empty stomach for three successive days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine 0.5 MG
Description: 0.5mg tablets (3times/day after meal for 3 days then twice daily for 4 days)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standared managment
Description: (Vitamin C 500mg tablet twice daily, Vitamin D3 2000-4000 IU/day, Zinc 75mg tablet once daily for two weeks
Study: NCT05706220

Intervention type: DIAGNOSTIC_TEST
Intervention: Microperimetry
Description: Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Intervention type: DIAGNOSTIC_TEST
Intervention: Microperimetry
Description: Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test
Study: NCT06105281

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The consultation with a pain specialist nurse
Description: When the participant receives a consultation with the pain specialist nurse ,there will be assessed if the patient knows what the procedure involves and what they can expect of it. To meet de expectations of the patient the nurse will explain the procedure and what they can expect. Further there will be an short education about what pain is and the physiology of chronic pain. Because chronic pain has a lot of influencing factors the nurse will explain the main factors.
Study: NCT05709509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Colchicine: A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. commonly used as anti-inflammatory drugs.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Colchicine: A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. commonly used as anti-inflammatory drugs.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention
Description: Percutaneous Coronary Intervention: a family of minimally invasive procedures used to open clogged coronary arteries (those that deliver blood to the heart)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention
Description: Percutaneous Coronary Intervention: a family of minimally invasive procedures used to open clogged coronary arteries (those that deliver blood to the heart)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Description: The subjects just received optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Study: NCT05706220

Intervention type: DIAGNOSTIC_TEST
Intervention: Microperimetry
Description: Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Intervention type: DIAGNOSTIC_TEST
Intervention: Microperimetry
Description: Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography (OCT)
Description: Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Intervention type: DIAGNOSTIC_TEST
Intervention: Visual processing speed test
Description: Visual processing speed test will be used for assessing subject visual stimulus search and reach times.~Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Intervention type: DIAGNOSTIC_TEST
Intervention: Visual processing speed test
Description: Visual processing speed test will be used for assessing subject visual stimulus search and reach times.~Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Intervention type: DIAGNOSTIC_TEST
Intervention: Visual processing speed test
Description: Visual processing speed test will be used for assessing subject visual stimulus search and reach times.~Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Intervention type: DIAGNOSTIC_TEST
Intervention: Visual processing speed test
Description: Visual processing speed test will be used for assessing subject visual stimulus search and reach times.~Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.
Study: NCT05884099

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoanalgesia AND single-injection paravertebral block
Description: CO2 Cryoanalgesia AND paravertebral block with Bupivacaine 0.5%

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-injection paravertebral block
Description: Paravertebral block with Bupivacaine 0.5%
Study: NCT06056609

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Yoga
Description: An 8 week online mother and baby yoga programme to include daily diary completion and questionnaires at designated study timepoints
Study: NCT05627674

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual care incorporates guideline awareness and brief advice.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RiskProfile-Clin
Description: RiskProfile-Clin incorporates standard brief advice and guideline awareness plus specific patient risk feedback using clinical factors.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RiskProfile-Gen
Description: RiskProfile-Gen incorporates standard brief advice and guideline awareness plus specific patient risk feedback using clinical factors and genetic factors.
Study: NCT06470893

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: OCD-NET
Description: OCD-NET is bibliotherapy with coaching and its content is reflective of standard care for OCD. OCD-NET is a self-paced intervention that participants complete entirely online with the support of an assigned individual therapist. Most participants complete this treatment in up to twelve weeks. On average, participants are expected to spend between one to five hours per week during the first half of treatment. In the second half of treatment when participants begin regular exposure and response prevention (ERP) exercises, participants are expected to spend about one hour per day.
Study: NCT06033807

Intervention type: DIAGNOSTIC_TEST
Intervention: QuantiFERON-TB Gold (QFT) test
Description: Participants will be tested by QuantiFERON-TB Gold (QFT) test to see if they have ever infected by MTB. Those with positive results will proceed to sputum Xpert MTB/RIF, physical examination and chest CT scan, as well as sputum culture if necessary to distinguish latent TB infection (LTBI) from ATB. X-ray scan is conditional on age above 15 years with a positive QuantiFERON-TB Gold (QFT) test result.
Study: NCT04261413

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RS-0139
Description: RS-0139 will be administered for the indication of solid tumors.
Study: NCT05407870

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etomidate Injection
Description: Proofol and etomidate are drugs used for sedation and have the same white color.~Gastric endoscopic submucosal dissection is performed using propofol in the control group and etomidate in the experimental group.~Efficacy and safety of sedatives were confirmed using propofol and etomidate.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol Injection
Description: Proofol and etomidate are drugs used for sedation and have the same white color.~Gastric endoscopic submucosal dissection is performed using propofol in the control group and etomidate in the experimental group.~Efficacy and safety of sedatives were confirmed using propofol and etomidate.
Study: NCT04544293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Molgramostim
Description: Molgramostim 300 µg nebulizer solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Molgramostim
Description: Molgramostim 300 µg nebulizer solution

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT04974151

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine besylate
Description: The amlodipine used in this study is a listed product.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate And Folic Acid
Description: The amlodipine besylate and folic acid tablets have been approved for listing by the China Food and Drug Administration, approval number: Zhunzi H20180020.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate And Folic Acid
Description: The amlodipine besylate and folic acid tablets have been approved for listing by the China Food and Drug Administration, approval number: Zhunzi H20180020.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-methyltetrahydrofolate (5-MTHF)
Description: The 5-MTHF used in this study is a listed product.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine placebo
Description: Amlodipine placebos are dummy pills of amlodipine with identical appearance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amlodipine placebo
Description: Amlodipine placebos are dummy pills of amlodipine with identical appearance.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine folic acid placebo
Description: Amlodipine folic acid placebos are dummy pills of amlodipine folic acid with identical appearance.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-MTHF Placebos
Description: 5-MTHF placebos are the dummy pills of 5-MTHF with identical appearance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-MTHF Placebos
Description: 5-MTHF placebos are the dummy pills of 5-MTHF with identical appearance.
Study: NCT05922761

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belumosudil
Description: Kinase inhibitor, tablet taken orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belumosudil
Description: Kinase inhibitor, tablet taken orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone
Description: Via inhalation by metered-dose inhaler.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin
Description: Semi-synthetic macrolide antibiotic, taken orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Corticosteroid, taken orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: Leukotriene Receptor Antagonist, taken orally
Study: NCT06370728

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Orforglipron
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: Administered orally
Study: NCT05918783

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
Description: Bronchoscopy will be performed with robotic assisted approach using standard practices using general anaesthesia and placement of the optic fiber intratumorally followed by IV administration of Padeliporfin for 10 min and laser light illumination.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
Description: Bronchoscopy will be performed with robotic assisted approach using standard practices using general anaesthesia and placement of the optic fiber intratumorally followed by IV administration of Padeliporfin for 10 min and laser light illumination.
Study: NCT06281353

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Curcumin Oral Capsule
Description: Curcumin oral capsule in nano-sized particle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trichloroacetic acid
Description: TCA 90%

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Trichloroacetic acid
Description: TCA 90%

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sample collection
Description: HIV and CD4+ 4th generation.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Blood sample collection
Description: HIV and CD4+ 4th generation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cotton swab
Description: Cotton swab for collecting sample from AGW lesions.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Cotton swab
Description: Cotton swab for collecting sample from AGW lesions.
Study: NCT06536101

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GIM-407
Description: GIM-407 oral dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo oral dose
Study: NCT06464367

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: synthetic psilocybin 10 mg (oral)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: synthetic psilocybin 10 mg (oral)
Study: NCT05709509

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Description: The subjects just received optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Description: The subjects just received optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.
Description: The subjects just received optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate.